Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OPK
.
.
I'd appreciate any thoughts on it. tia
SCON..$1.02 Solid DD. Bought today (for a trade) at $1.02 near the close off the alert post. Thx.
SCON DD (!) - Placement done, milestones to come.
With recent placement at 1.05 for 4 million they are about ready to start installing their new state of art production facililty
- New low cost technology for Superconducting Wire
- Product samples meeting industry criteria and validated !
- Took possesion of new 90.000 acre state of art facility in January 2012
"The company will set up in a 94,000-square-foot Class A semiconductor manufacturing facility previously occupied by Applied Materials Inc"
Here an overview of their plans.
Note the wire cost with is lot less than some of their competitors allready in the market such as AMSC
Wire cost projections
Full update in pdf here: http://www.suptech.com/pdf_presentations/2012invpresentation.pdf
Production partner likely there due to supply restraints in the sector.
Recent and more outlook there than there was before, worth the read:
http://www.statesman.com/business/technology/vacant-clean-rooms-find-new-life-in-superconducting-2039934.html
A) Superconductor . Technologies Inc. Takes Possession of Advanced Manufacturing Center of Excellence in Austin, TX
http://finance.yahoo.com/news/Superconductor-Technologies-pz-3998953240.html?x=0
B) Superconductor Technologies Inc. Completes Testing of Conductus(R) 2G HTS Wire with General Cable Superconductor Ltd. for HTS Roebel Cable Applications
Successfully meeting critical current and power handling objectives
http://finance.yahoo.com/news/Superconductor-Technologies-pz-2107429496.html?x=0
C)Superconductor Technologies Inc. Commits Supply of Conductus(R) 2G HTS Wire to Leading Provider of High Power Transmission Cables Demonstration project scheduled to be completed by end of 2012
http://finance.yahoo.com/news/Superconductor-Technologies-pz-1237715445.html?x=0
SCON..$1.01 Good DD post and early alert. Much appreciated!
Thanks for the feedback there, nice to hear the post was appreciated.
Did you get a chance to add today. Not sure what next catalyst is for GNOM, I know they are ramping up, and trying to do more services, and maybe add some partners like MAYO. Other than earning next month do you know anything else that can propel it.
GQ
Thanks for the SCON alert.
Got a nice position at 0.93-0.95 and will hold for a bounce.
Thanks.
GRVY..$2.79 has been churning all day after starting the morning strong hitting a high of $2.98.
PLX..$5.57 Looks like it was ready at about $5.50. Good to see. Onward & upward.
GNOM - $3.90
Added
ECYT was churning like my stomach.
showing some life during the mid day cycle!
gl
GRVY: Promotion....not ads.
My last post is a bit misleading upon second reading.
The game is being promoted in China but I can not say that its from the GRVY advertising budget.
ALXA..$.49 Shareholders getting slammed today. What a shame and disappointment this stock has turned out to be.
VVUS..$12.16 stock is trading like a beast today. Looks like euphoria that there are no huge surprises in the briefing docs
GRVY: RO2 ads in China running today. Link
They just put them a little earlier.
Chian is a fairly big country, of course. :)
Hit Translate:
http://xin.178.com/201202/123466700524.html
ALXA:Alexza Prices $22 Million Public Offerin
PPS:.50
http://finance.yahoo.com/news/Alexza-Prices-22-Million-prnews-2643642636.html?x=0
Investor 100
HZNP..$3.42 Looks like a strong opportunity here. Right at the 52wk low. The reaction is way overdone from this PR. Looks like a biotech play at the bottom. The book value per share is $6.57.
http://finance.yahoo.com/news/Horizon-Receives-Notice-iw-3785158728.html?x=0
GRVY: Eamil from Gravity just received. 9:55am est.
It is clear that the very conservative GRVY management has been biding its time as far as media coverage to make certain that the launch is off and running before they strat beating the media drum. That should start as as soon as they light up after this long weekend.....early next week.
Dear Mr. XXXXXX
Thank you very much for your kind words.
We will make every efforts in order to give better idea of the true value of Gravity to the USA media as well as investor community. We always wanted to do more interviews and issue more press releases but we could not in the past years due to the long delay of Ragnarok Online?. We are going to strengthen our IR and PR activities once the game is released. That is our management’s plan.
It is great to see there are more and more investors who have interest in Gravity. We will do our best not to disappoint them and to raise long-term shareholder value.
It is about 10:30 p.m. KST and I believe all the developers at Ragnarok Online team who are still in the office know very well how much the game means to our shareholders, the fans of Ragnarok as well as Gravity.
Once again, thank you very much for your support and encouragement.
I hope you have a great weekend.
Kind regards,
Yoon Joo Lee
IR Manager
Gravity Co., Ltd.
SCON placement - turnaround play , adding in size today
BRIEF-Superconductor Technologies to raise $4.6 million
Feb 17 (Reuters) - Superconductor Technologies Inc <SCON.O>:
* To raise $4.6 million in registered direct offering
* Agreements with certain institutional investors for placement of common stock
at $1.05 per share
* Will also issue to the investors warrants to purchase up to about 3.3 million
shares of common stock
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
((For more news, please click here [SCON.O]))
Probably a misprint or someones fingers were too fat....
extremely strange....
below is from etrade.
EXTENDED HOURS:
Last: 4.35
Change: -6.49 (-59.87%)
Bid: 10.42 x700
Ask: 11.48 x200
below is from nasdaq.com (no change)
http://www.nasdaq.com/symbol/affy/after-hours
gl
For those of us that missed the afterhours sell message on AFFY the other day, lets pray the a.m. print on AFFY is a misprint @ $4.35
From my AMTD streamer this morning"
RBCC Sets Sights on Top Emerging Biotech InnovationsLast update: 2/17/2012 5:00:00 AMNOKOMIS, Fla., Feb 17, 2012 (BUSINESS WIRE) -- With Rainbow Coral Corp.'s (RBCC) funding agreement with n3D Bioscience nearly complete, the company's executive leadership will seek out lucrative new business opportunities at Texas' premiere life science venture forum in March. Houston's top biotech incubators, the Rice Alliance and BioHouston, have joined forces and combined conferences to create the Texas Life Science Venture Forum (TLSVF), the state's largest life science event. The forum is part of the three-day Texas Life Science Conference which is the premiere life science venture conference in the state. The conference will be the most comprehensive showcase of cutting-edge research and innovative entrepreneurs in the state, with hundreds of national and local venture capitalists in attendance. TLSVF will serve as the vehicle for RBCC execs to network with Houston's top biotech entrepreneurs and investors as the company targets new opportunities in the life science sector. Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Amgen Inc. (AMGN), Cell Therapeutics, Inc. (CTIC), Abbott Laboratories (ABT) and Affymax, Inc. (AFFY). For more information on Rainbow BioSciences, please visit .
GRVY: RO2 ad campaign under way. 2/17/2012
The RO2 advertising campaign in South Korea has started in the last few hours according to two sources.
Mostly pop-up ads and the like so far touting 2/22 as the date for open beta and commercial launch a few days later.
That is very good news because it confirms that the years of delay are over and GRVY is now about to light this candle.
The actual news release here in the United States is due in "late Feb." according to IR as of 48 hours ago.
Not sure what they consider "late" but it has to be soon.............lol
best of luck.
CTIC:European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™
Potentially the First Drug to be Approved as Monotherapy for the Treatment of Adult Patients with Multiple Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas (NHL)
Feb. 17, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today that Pixuvri™ (pixantrone dimaleate) has been granted a positive opinion for conditional approval from the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"). Based on the CHMP's recommendation, CTI expects that a conditional marketing authorization for Pixuvri should be granted by the European Commission within the next few months. CHMP recommended Pixuvri for conditional approval as monotherapy for the treatment of adult patients with multiple relapsed or refractory aggressive non-Hodgkin B-cell
http://finance.yahoo.com/news/European-Medicines-Agency-prnews-3852222269.html?x=0
Investor 100
Future Link & Business News
http://www.finviz.com/futures.ashx
Investors on edge awaiting Greek bailout
NEW YORK (CNNMoney) -- U.S. stocks were headed for a flat open Friday, after finishing the previious session at multi-year highs, as investors hesitated to make big bets before Greece secures a second bailout to avoid a default.
http://money.cnn.com/2012/02/17/markets/premarkets/index.htm?iid=Lead
FDA warns of toothbrushes that mess up your face
The U.S. Food and Drug Administration issued a consumer safety update Thursday about a brand of electric toothbrushes that's been found to chip teeth, cut gums and generally wreak havoc with your face.
http://vitals.msnbc.msn.com/_news/2012/02/16/10428340-fda-warns-of-toothbrushes-that-mess-up-your-face
Chrysler drops application for government loan
http://www.msnbc.msn.com/id/46420234/ns/business-autos/
Investor 100
GILD says prior Hep C null responders suffer viral relapse after treatment w. GS-7977 + RBV. Regimen not potent enough.
GRVY: Wikipedia page updated.
Significant information here.
This link will give readers a flavor of the complexity of the Raganarok Online virtual world.
As noted before, the original Ragnarok MMORPG, (Massively multi-player role playing game), had over 40 million players in 80 countries and still has a large following playing this game.
The game was delayed for years while Gravity worked and reworked the virtual world.
The Feb. 22, 2012 global roll out starts In South Korea and expands from there.
Ragnarok Online 2: Legend of the Second is not a one shot money maker for GRVY.
It is designed to last for years (with updates every 3 months) and to be a source of huge income for Gravity for quite some time.
The bottom line is GRVY, imo, has a monster virtual goods cash machine in RO2 and it should be a sensational income generator for Gravity and its investors.
http://en.wikipedia.org/wiki/Ragnarok_Online_2:_Legend_of_the_Second
Note: The global roll out will take months, not days, as country after country lights up. This of course involves many licensing deals with various delivery platforms both stationary and mobile. Many of these deals will involve rolling over deals that are already in place for the current game, of course.
to approve or not to approve, ode to adam!
http://www.thestreet.com/_yahoo/story/11421978/1/these-drugs-stocks-will-win-fda-approval.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
gl
Took starter position @ GRVY at $2.65
Solid "DD" once again Sheff and also kudos to GlobeTtrade on posting it at the Sheff Station!
Investor 100
GGguy-
No I am out but looking to re-enter below $4
GL
Investor 100
Yelp.
its an evolving business with progressive losses at the early stages of development. Is it a search engine or a yellow pages platform. the dichotomy and potential ,makes this intriguing.
http://www.bloomberg.com/news/2012-02-16/yelp-seeks-to-raise-as-much-as-100-million-in-ipo-of-user-review-website.html
similar to linkdn IPO, Opentable IPO; i do like the yelp IPO in potential, though it may open flat.
should be an interesting opportunity, as revenue and platform is more forcastable than Groupon & zynga (which i did not like).
concerns of Yelp:
http://www.bloomberg.com/video/85826512/
gl
CORT: can not wait for CRL tomorrow.
GRVY: The Virtual Goods Model via Wiki.
Its important to get a grip on this concept and the type of sick money it can generate.
In fact, selling nothing for something.
http://en.wikipedia.org/wiki/Virtual_good
AMRN..$9.28 What a move today. Excellent to see this kind of volative ascension on the screen. Patience has been key here as the downward mvmt on the stock was driving me crazy.
GRVY..$2.65 DD Post here with key links to news.
Yesterday this traded 1.03m shares & had a monster move on a down day. Today's volume is equally as strong. The key near-term catalyst date for this stock is Feb 22nd. RO2 release starts on 2/22/12. GRVY (Gravity) has not traded over 1m shares since 2009. The most it has traded in the last few yrs was on Feb 6th where it traded 689,300 shares. The O/S is about 28m & the float is only 11m.
This was the Nov 2011 data discussing Ragnarok II coming in early 2011. http://bit.ly/rFGRpp
News from Gravity new website http://ro2.gnjoy.com/ &
new trailer link http://www.youtube.com/watch?v=1ppjCbFnVL0
SCON investment update !
Note the projected cost of wire, thats massively lower than AMSC wire
http://www.suptech.com/pdf_presentations/2012invpresentation.pdf
GNOM - $4.08
Yes, I reentered today at $4.05
GRVY..$2.68 Finishing up a comprehensive DD post that I will put out before the end of the trading day. Has all the links & DD to this play. Did not get a chance yesterday to complete one & I usually like to do that.
On another note..Almost 800K in volume traded today. Today's volume will break all of the previous records for volume for GRVY. Still 3 hrs left in the trading day. Volume before price is usually seen in these low float stocks.
interesting trading in ECYT.
lot of nibbling, teetering till someone flinches.
gl
GNOM- 4.10 went green for the day after the lawsuit news.
SATC is getting ready for silver cross
http://www.findata.co.nz/markets/stockquote/NASDAQ/SATC.htm
DCTH,
Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System
Delcath (NASDAQ:DCTH)
Intraday Stock Chart
Today : Thursday 16 February 2012
Click Here for more Delcath Charts.Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Company has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT® Delivery system with University Medical Center Schleswig-Holstein (Kiel Campus), one of the largest European centers for medical care and the second cancer center in Germany to commercially utilize the CHEMOSAT system to treat patients. Under the terms of the agreement, the Company will provide the University Medical Center Schleswig-Holstein with logistics and clinical training support in the performance of chemosaturation therapy using the CHEMOSAT system. Training at the University Medical Center Schleswig-Holstein is expected to begin in April 2012.
Prof. Dr. med. Thomas Becker, Director of the Department of General and Thoracic Surgery, said, "I am excited that our medical center will begin using Delcath's CHEMOSAT system to treat cancers in the liver. Gaining experience with this device and procedure is in line with our international reputation for leadership in medical care as well as excellent research results."
Axel Hauschild, MD, Professor of Dermatology in the Department of Dermatology, said, "Our team is committed to translating novel scientific developments and findings into new options for therapies. Clinical research suggests that CHEMOSAT will offer us a clinically significant tool in treating melanoma liver metastases with melphalan, and we're eager to begin providing therapy to our patients."
"We are proud of the addition of University Medical Center Schleswig-Holstein to the growing number of European sites providing therapy with the CHEMOSAT system," said Eamonn P. Hobbs, President and CEO of Delcath Systems. "This second clinical site in Germany not only expands the access in the largest market in Europe, but provides further validation that our years of research and development have produced a product that's attracting the interest of Europe's best cancer centers."
About the University Medical Center Schleswig-Holstein
The University Medical Center Schleswig-Holstein is one of the largest European centers for medical care. As the only maximum care provider in Schleswig-Holstein it covers the entire spectrum of modern medical and health care. At the University Medical Center Schleswig-Holstein, 2,000 physicians, scientists and researchers, and 3,600 health staff treat over 360,000 inpatients and outpatients in 80 clinics and institutes.
About Delcath Systems
Delcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to: the future use and adoption of the CHEMOSAT system by the University Medical Center Schleswig-Holstein, future initial launch and training agreements with other cancer centers in Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.
Contact Information:
Investor Contact:
Media Contact:
Doug Sherk/Gregory Gin
Janine McCargo
EVC Group
EVC Group
415-568-4887/646-445-4801
646-688-0425
SOURCE Delcath Systems, Inc.
GRVY: FaceBook news.
IR and PR were planning on waiting until early Q2, a few weeks, to PR the FaceBook news.
They did not want to step on the long planned and very complicated RO2 rollout that starts on 2/22.
Investors, however, are showing huge interest in the FaceBook news and making requests of GRVY to put out a FaceBook mobile social games update right away.
I did so and others as well and urge all GRVY to also do it.
Imo, GRVY, located in Korea and Japan did not understand the truw impact that news would have and only became aware a few days ago.
GRVY IR is: Ms. Lee.....IRcommunication@Gravity.co.kr.
She is quite responsive and highly professional, by the way
NOTE: EGT is sstarting to move nicely as well. many of the early GRVY investors are loading up there as well.
THLD powering higher. News due out on Phase 2 any day
GRVY..$2.68 A pending catalyst here is Feb 22nd. This is the company website link in anticipation of that. http://ro2.gnjoy.com/intro.asp
GNOM"..anyone in this. Investor or taxi are you still in this.
GQ
ECYT...$3.69 Pulled back a little but they still have 2 investment conf upcoming in late Feb. Citbank on 27th and RBC capital 28th.
Follow Me on Twitter: http://twitter.com/SheffStation/
New Economy Portfolio: Larger Cap stocks for slower but more consistent gains. Some Longer-Term Plays (30-60 days maybe longer)
Beginner Portfolio: Scalp Plays & Low Float Biotechs for potential explosive Growth. Quick Turnover 1-30 days (smaller balance want aggressive growth)
Position Size: STARTER: (1-5% Portfolio Balance) SOLID: (6-10% Portfolio Balance) FULL : (11-20% Portfolio Balance)
NEW ECONOMY PORTFOLIO | Sell Date | Ticker | Buy PPS | Sell PPS | Gain/Loss | Notes | % + or - | ||
| |||||||||
|
| ||||||||
|
| | |||||||
|
| ||||||||
|
| | |||||||
|
| | |||||||
| |||||||||
| | ||||||||
Beginner Portfolio Economy | | ||||||||
BUY DATE | SELL DATE | TICKER | BUY PPS | SELL PPS | Gain/Loss | NOTES | % + or - | ||
|
| ||||||||
| | ||||||||
| |||||||||
| |||||||||
| |||||||||
$HEFF LEARNING STATION-LINKS
REAL-TIME Futures Quotes: http://www.sgxniftydowfutureslive.com/index_files/DOWFUTURES.htm …
JANNEY HEALTHCARE NEWSLETTER-http://www.janney.com/institutions--corporations/investment-banking/industry-groups/healthcare/life-sciences-newsletter
Traders: Develop Your Mental Edge by Dr. Andrew Menaker http://j.mp/1phyFIY
Jesse Livermore-Reminiscences Of A Stock Operator-Great Book http://bit.ly/VOObyM
LIFE SCIENCES MARKET : http://www.thelifesciencesreport.com CHMP Decisions Here: http://t.co/7jjqFyn3tx
E-booklet onTrend Determination: A quick accurate and effective methodology using RSI. http://bit.ly/17PmHZ8
The Original Turtle Trading Rules: Rules of the “Turtle Traders;” one of the greatest trading experiments conducted.
http://bit.ly/17jXegf
FAVORITE QUOTES:
"Compounding interest is the eighth wonder of the world. He who understands it, earns it..he who doesn't.. pays it." - Albert Einstein
"Your actions speak so loud I can't hear your words! When that happens, you have found a certain level of success others haven't." Sheff
"IF YOU ARE NOT TAKING YOUR PROFITS, SOMEBODY ELSE IS !" SHEFF
A good name is more desirable than great wealth. Respect is better than silver or gold. -Proverbs 22:1
Don't brag about yourself let others praise you. -Proverbs 27:2
Do not brag about tomorrow, because you do not know what another day may bring. -Proverbs 27:1
One man pretends to be rich, yet has nothing. Another pretends to be poor, yet has great wealth. Proverbs 13:7
You can easily judge the character of a man by how he treats those who can do nothing for him. -James D. Miles
Favorite Sheff Quote: "You can't let praise or criticism get to you. It's a weakness to get caught up in either one." -John Wooden
Favorite Sheff Quote: Talent is God given. Be humble. Fame is man-given. Be grateful. Conceit is self-given. Be careful.
A Trading Plan = Study. A watch-list. Position Sizing. Entries. Exits. Records. Discipline. h/t @sjburns
5 Things I didn't come on twitter to do: Convince anyone of anything , Argue Defend myself Battle Trolls Waste time @sjosephburns
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |